Announcement on Engagement of Audit Institution for 2025
Filed with SSE · · 5 pages · Chinese
Summary by 6ix AI
This change is aimed at ensuring the smooth progress of the annual audit work, considering the company's business needs. The decision has been communicated with the previous auditor, who has no objections to the change.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Lionco Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Lionco Pharmaceutical
- Announcement on Interest Payment for Corporate Convertible Bonds
- Announcement on Handling of Pledge of Partial Shares of Controlling Shareholder
- Report for Q3 2025
- Announcement on Subsidiary’s Prospective Winning in the National Centralized Drug Procurement
- Announcement on Resolutions of the 1st Meeting of the 5th Board of Directors
Later from Lionco Pharmaceutical
- Announcement on No Downward Revision of Conversion Price of ""Lionco Convertible Bonds"
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on ""Corporate Value and Return Enhancement"" Action Plan
- Earnings Preannouncement for 2025
- Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors
Follow Lionco Pharmaceutical into a list and get an email when it puts out news.
Follow Lionco Pharmaceutical